link_id stringlengths 25 25 | evidence_group_id stringlengths 22 22 | pmid int64 1.8M 42.2M | nct_id stringlengths 11 11 | claim_type stringclasses 6
values | claim_direction stringclasses 6
values | claim_strength stringclasses 3
values | n_results int64 0 126 | outcome_types_present stringclasses 5
values | result_ids stringclasses 249
values | checkability stringclasses 2
values | verification stringclasses 1
value | evidence_span stringclasses 21
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLAIM_RESULT_105dd2554b56 | CLUST_6318117fa8d081c7 | 29,133,948 | NCT00693849 | superiority_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | reduced |
CLAIM_RESULT_4ea6d47d8e46 | CLUST_6bdcbfca67b2cd20 | 29,115,994 | NCT02590185 | efficacy_claim | unclear | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_a18baeabfba7 | CLUST_e2aedcafeee72f35 | 29,111,077 | NCT01562184 | no_difference_claim | no_difference | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | no difference |
CLAIM_RESULT_c3cdd027a5a6 | CLUST_e2aedcafeee72f35 | 29,111,077 | NCT01562184 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_eac5f5d63a3e | CLUST_e2aedcafeee72f35 | 29,111,077 | NCT01562184 | efficacy_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_ffa1ad302508 | CLUST_e5440d4cfd0abd72 | 29,101,402 | NCT00946998 | association_claim | associated | source_reported | 5 | PRIMARY; SECONDARY | RESULT_22a1dfc1c0e5; RESULT_9e29e9098996; RESULT_f67fd29e02ee; RESULT_eabe03b874dc; RESULT_bbfe87fe3353 | checkable | not_assessed | associated with |
CLAIM_RESULT_dafa90afa792 | CLUST_e5440d4cfd0abd72 | 29,101,402 | NCT00946998 | efficacy_claim | associated | statistically_supported | 5 | PRIMARY; SECONDARY | RESULT_22a1dfc1c0e5; RESULT_9e29e9098996; RESULT_f67fd29e02ee; RESULT_eabe03b874dc; RESULT_bbfe87fe3353 | checkable | not_assessed | efficacy |
CLAIM_RESULT_8519be4b6ac2 | CLUST_f420e90434d02cbf | 29,056,608 | NCT02045771 | association_claim | improved | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_49886ff32ce2 | CLUST_f420e90434d02cbf | 29,056,608 | NCT02045771 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_8b789000fbf7 | CLUST_622b124875e640fa | 29,035,574 | NCT01491035 | safety_claim | unclear | source_reported | 7 | PRIMARY | RESULT_914a0172da35; RESULT_b0394824ea0a; RESULT_0b704b28b74c; RESULT_976eff75ee65; RESULT_31c71ee9d175; RESULT_089090fc023c; RESULT_ee7affee03de | checkable | not_assessed | well tolerated |
CLAIM_RESULT_14dc27658d2b | CLUST_622b124875e640fa | 29,035,574 | NCT01491035 | efficacy_claim | unclear | source_reported | 7 | PRIMARY | RESULT_914a0172da35; RESULT_b0394824ea0a; RESULT_0b704b28b74c; RESULT_976eff75ee65; RESULT_31c71ee9d175; RESULT_089090fc023c; RESULT_ee7affee03de | checkable | not_assessed | efficacy |
CLAIM_RESULT_b67c5690be3a | CLUST_96addb5fd1c6a593 | 28,926,793 | NCT00739908 | association_claim | associated | source_reported | 7 | PRIMARY; SECONDARY | RESULT_a3ed767eb98a; RESULT_de32a5754303; RESULT_68d76932a129; RESULT_e78a9b371e77; RESULT_9de15ce883b2; RESULT_dd119aa301d8; RESULT_e2fa1c6130c8 | checkable | not_assessed | increased |
CLAIM_RESULT_7ecfb84aa03b | CLUST_96addb5fd1c6a593 | 28,926,793 | NCT00739908 | association_claim | associated | source_reported | 7 | PRIMARY; SECONDARY | RESULT_a3ed767eb98a; RESULT_de32a5754303; RESULT_68d76932a129; RESULT_e78a9b371e77; RESULT_9de15ce883b2; RESULT_dd119aa301d8; RESULT_e2fa1c6130c8 | checkable | not_assessed | associated with |
CLAIM_RESULT_cf25dcb04220 | CLUST_80d3afd5bf395f88 | 28,882,405 | NCT01197846 | superiority_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | more effective than |
CLAIM_RESULT_5d26672de3e7 | CLUST_80d3afd5bf395f88 | 28,882,405 | NCT01197846 | safety_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | adverse events were |
CLAIM_RESULT_a83dc21f0f07 | CLUST_80d3afd5bf395f88 | 28,882,405 | NCT01197846 | efficacy_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_26d314d779b4 | CLUST_11961182633179e4 | 28,858,412 | NCT01255787 | safety_claim | unclear | source_reported | 5 | PRIMARY; SECONDARY | RESULT_269626b37583; RESULT_72ec66a78ca1; RESULT_c0859e3e1d49; RESULT_b318cb65747e; RESULT_fd2f9aecacee | checkable | not_assessed | well tolerated |
CLAIM_RESULT_fa9c5093b942 | CLUST_11961182633179e4 | 28,858,412 | NCT01255787 | efficacy_claim | unclear | source_reported | 5 | PRIMARY; SECONDARY | RESULT_269626b37583; RESULT_72ec66a78ca1; RESULT_c0859e3e1d49; RESULT_b318cb65747e; RESULT_fd2f9aecacee | checkable | not_assessed | efficacy |
CLAIM_RESULT_b1f2eb1eea07 | CLUST_857c764a0152378d | 28,857,719 | NCT01435759 | superiority_claim | improved | statistically_supported | 4 | PRIMARY; SECONDARY | RESULT_bac9b9bf6c28; RESULT_f1b2d7fc7abd; RESULT_555cdb283b5e; RESULT_2da369751ad6 | checkable | not_assessed | increased |
CLAIM_RESULT_2418660a09f2 | CLUST_857c764a0152378d | 28,857,719 | NCT01435759 | efficacy_claim | improved | statistically_supported | 4 | PRIMARY; SECONDARY | RESULT_bac9b9bf6c28; RESULT_f1b2d7fc7abd; RESULT_555cdb283b5e; RESULT_2da369751ad6 | checkable | not_assessed | efficacy |
CLAIM_RESULT_1ec5edc077e5 | CLUST_4e7a026f3ab4be13 | 28,857,658 | NCT02263872 | superiority_claim | unclear | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_5c1b03927902 | CLUST_4e7a026f3ab4be13 | 28,857,658 | NCT02263872 | efficacy_claim | unclear | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | effective in |
CLAIM_RESULT_a6cd167be154 | CLUST_ea98fb7f35313ac9 | 28,841,824 | NCT01075529 | safety_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | adverse events were |
CLAIM_RESULT_23ae49e762f0 | CLUST_ea98fb7f35313ac9 | 28,841,824 | NCT01075529 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_d84012d379e1 | CLUST_58d7841b29dad9f8 | 28,789,578 | NCT01832805 | superiority_claim | no_difference | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_9d6f4128aa23 | CLUST_58d7841b29dad9f8 | 28,789,578 | NCT01832805 | no_difference_claim | no_difference | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | no difference |
CLAIM_RESULT_e8599bd830be | CLUST_e86c9e82d083f1cb | 28,768,493 | NCT02327858 | efficacy_claim | unclear | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_26381a9d2db4 | CLUST_5801e16c9df9700e | 28,731,778 | NCT00943085 | association_claim | unclear | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | linked to |
CLAIM_RESULT_9666564210f1 | CLUST_030ed574d8ea6a0a | 28,705,252 | NCT02529462 | superiority_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | reduced |
CLAIM_RESULT_8804dd83f569 | CLUST_4d610791b6abd7bc | 28,697,253 | NCT01421342 | superiority_claim | associated | statistically_supported | 4 | PRIMARY; SECONDARY | RESULT_f68f3a81ed8b; RESULT_582b9f5b9266; RESULT_6d4a83504873; RESULT_3cf0741ee7c8 | checkable | not_assessed | increased |
CLAIM_RESULT_bff1405cd01a | CLUST_4d610791b6abd7bc | 28,697,253 | NCT01421342 | association_claim | associated | source_reported | 4 | PRIMARY; SECONDARY | RESULT_f68f3a81ed8b; RESULT_582b9f5b9266; RESULT_6d4a83504873; RESULT_3cf0741ee7c8 | checkable | not_assessed | associated with |
CLAIM_RESULT_30d466e5d134 | CLUST_fd1c37cc0af3f7c1 | 28,663,124 | NCT01364649 | superiority_claim | improved | directionally_supported | 3 | PRIMARY; SECONDARY | RESULT_b265544edbf8; RESULT_ef81b2aeb975; RESULT_e43aaf61125e | checkable | not_assessed | superior to |
CLAIM_RESULT_c9b97c106d9b | CLUST_fd1c37cc0af3f7c1 | 28,663,124 | NCT01364649 | safety_claim | improved | directionally_supported | 3 | PRIMARY; SECONDARY | RESULT_b265544edbf8; RESULT_ef81b2aeb975; RESULT_e43aaf61125e | checkable | not_assessed | well tolerated |
CLAIM_RESULT_0efb8a45a30f | CLUST_fd1c37cc0af3f7c1 | 28,663,124 | NCT01364649 | efficacy_claim | improved | directionally_supported | 3 | PRIMARY; SECONDARY | RESULT_b265544edbf8; RESULT_ef81b2aeb975; RESULT_e43aaf61125e | checkable | not_assessed | efficacy |
CLAIM_RESULT_fc93497e5945 | CLUST_1f2e3a97478e0913 | 28,657,871 | NCT01894815 | superiority_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | superior to |
CLAIM_RESULT_e1874a6dc2a0 | CLUST_1f2e3a97478e0913 | 28,657,871 | NCT01894815 | non_inferiority_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | noninferior |
CLAIM_RESULT_1c5c4d3b49ef | CLUST_1f2e3a97478e0913 | 28,657,871 | NCT01894815 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_3eaaecb9ef3b | CLUST_c97bbdabcd79fb54 | 28,651,526 | NCT03004521 | superiority_claim | worsened | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | superior to |
CLAIM_RESULT_7e6421dff527 | CLUST_c97bbdabcd79fb54 | 28,651,526 | NCT03004521 | association_claim | worsened | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_c0f421bac618 | CLUST_25ff1cf84e4a196a | 28,648,567 | NCT02615405 | superiority_claim | no_difference | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_c5f821d01d56 | CLUST_25ff1cf84e4a196a | 28,648,567 | NCT02615405 | no_difference_claim | no_difference | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | did not differ |
CLAIM_RESULT_8283945a7acf | CLUST_25ff1cf84e4a196a | 28,648,567 | NCT02615405 | association_claim | no_difference | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_cf1b01087438 | CLUST_25ff1cf84e4a196a | 28,648,567 | NCT02615405 | efficacy_claim | no_difference | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_a76475e59cfd | CLUST_4e7a026f3ab4be13 | 28,628,884 | NCT00590863 | association_claim | associated | source_reported | 2 | PRIMARY; SECONDARY | RESULT_4524423aecad; RESULT_737d99a18c27 | checkable | not_assessed | increased |
CLAIM_RESULT_118203589d4a | CLUST_4e7a026f3ab4be13 | 28,628,884 | NCT00590863 | association_claim | associated | source_reported | 2 | PRIMARY; SECONDARY | RESULT_4524423aecad; RESULT_737d99a18c27 | checkable | not_assessed | correlated with |
CLAIM_RESULT_64b8b006d06a | CLUST_bbe6c6e4b5dde631 | 28,628,768 | NCT02366429 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_1a02b23960cb | CLUST_bbe6c6e4b5dde631 | 28,628,768 | NCT02366429 | efficacy_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_8663daf3a87a | CLUST_c1242bc2986d21b8 | 28,619,114 | NCT03033420 | efficacy_claim | unclear | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | effective in |
CLAIM_RESULT_20cd4d82d89d | CLUST_7b031db1cc05180a | 28,582,570 | NCT01554176 | safety_claim | unclear | statistically_supported | 8 | PRIMARY; SECONDARY | RESULT_138bbc57de9e; RESULT_24f0c9723884; RESULT_1795e8f095f0; RESULT_a868328cc4b4; RESULT_2cf0d82e892e; RESULT_3bd6b3b64ece; RESULT_1f4591fe9506; RESULT_0184d115e03c | checkable | not_assessed | adverse events were |
CLAIM_RESULT_e9083f74380d | CLUST_7b031db1cc05180a | 28,582,570 | NCT01554176 | efficacy_claim | unclear | statistically_supported | 8 | PRIMARY; SECONDARY | RESULT_138bbc57de9e; RESULT_24f0c9723884; RESULT_1795e8f095f0; RESULT_a868328cc4b4; RESULT_2cf0d82e892e; RESULT_3bd6b3b64ece; RESULT_1f4591fe9506; RESULT_0184d115e03c | checkable | not_assessed | efficacy |
CLAIM_RESULT_f63e9ec6a42e | CLUST_c7d7530618438876 | 28,570,792 | NCT01619631 | safety_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | adverse events were |
CLAIM_RESULT_0f10b0e4cfe3 | CLUST_72b70646244f50f9 | 28,554,910 | NCT02404662 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_49b8807f95c0 | CLUST_23f5618d952852af | 28,509,904 | NCT01464463 | superiority_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | reduced |
CLAIM_RESULT_6025e2ce62f7 | CLUST_23f5618d952852af | 28,509,904 | NCT01464463 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_9394706dfe4c | CLUST_33a274dbef723264 | 28,445,632 | NCT00056472 | association_claim | associated | source_reported | 3 | OTHER_PRE_SPECIFIED; PRIMARY; SECONDARY | RESULT_b7ab96dc358b; RESULT_f3b660e59046; RESULT_871d9b3c6246 | checkable | not_assessed | associated with |
CLAIM_RESULT_423cdec7f29a | CLUST_dd3caad60478527c | 28,423,145 | NCT01147614 | superiority_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | superior to |
CLAIM_RESULT_4a98e09c256a | CLUST_dd3caad60478527c | 28,423,145 | NCT01147614 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_ebc5e80863e5 | CLUST_32775bd54e351cb3 | 28,422,269 | NCT02047968 | efficacy_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_1ddbdb6350b4 | CLUST_b63e08c7300e65bd | 28,420,367 | NCT02312583 | efficacy_claim | unclear | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_a6da3ee1ed84 | CLUST_0163354f3580cec8 | 28,414,583 | NCT00621777 | safety_claim | unclear | source_reported | 3 | PRIMARY; SECONDARY | RESULT_da904594cb39; RESULT_14b76cafc61e; RESULT_4365c25d33e6 | checkable | not_assessed | safety profile |
CLAIM_RESULT_b6b566f93ca9 | CLUST_4e7a026f3ab4be13 | 30,824,246 | NCT00021528 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_45082feeacc0 | CLUST_4e7a026f3ab4be13 | 30,824,246 | NCT00118404 | association_claim | improved | directionally_supported | 3 | PRIMARY | RESULT_5145c0a12e8d; RESULT_23245635ef00; RESULT_cac04180629f | checkable | not_assessed | associated with |
CLAIM_RESULT_24351c0392d9 | CLUST_d35de3b3fa42da6d | 30,699,881 | NCT01717040 | efficacy_claim | unclear | statistically_supported | 1 | PRIMARY | RESULT_77cf0f4167a7 | checkable | not_assessed | efficacy |
CLAIM_RESULT_61b83149e801 | CLUST_4d610791b6abd7bc | 30,695,291 | NCT01421342 | no_difference_claim | no_difference | statistically_supported | 4 | PRIMARY; SECONDARY | RESULT_f68f3a81ed8b; RESULT_582b9f5b9266; RESULT_6d4a83504873; RESULT_3cf0741ee7c8 | checkable | not_assessed | no significant difference |
CLAIM_RESULT_9f96a055c80d | CLUST_e1d28f09a8a1afe5 | 30,503,506 | NCT01515215 | association_claim | unclear | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | linked to |
CLAIM_RESULT_70654db99757 | CLUST_f2dacb28a7eed9c1 | 30,431,297 | NCT01178424 | association_claim | improved | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | reduced |
CLAIM_RESULT_4930cdf3d632 | CLUST_f2dacb28a7eed9c1 | 30,431,297 | NCT01178424 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_ec04fadef60d | CLUST_a2546dba42a63671 | 30,423,468 | NCT01537068 | no_difference_claim | no_difference | statistically_supported | 3 | PRIMARY; SECONDARY | RESULT_0a89aaa09541; RESULT_5358281b7738; RESULT_81c34c18902e | checkable | not_assessed | did not differ |
CLAIM_RESULT_ec5d68c42eec | CLUST_22de8c722308c426 | 30,423,462 | NCT01533285 | superiority_claim | unclear | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_9c107b544d1d | CLUST_4e7a026f3ab4be13 | 30,370,613 | NCT00590863 | association_claim | associated | source_reported | 2 | PRIMARY; SECONDARY | RESULT_4524423aecad; RESULT_737d99a18c27 | checkable | not_assessed | increased |
CLAIM_RESULT_e7232e8be712 | CLUST_4e7a026f3ab4be13 | 30,370,613 | NCT00590863 | association_claim | associated | source_reported | 2 | PRIMARY; SECONDARY | RESULT_4524423aecad; RESULT_737d99a18c27 | checkable | not_assessed | associated with |
CLAIM_RESULT_bf360d90c7e6 | CLUST_97b02e6f96d0117c | 30,368,163 | NCT01912196 | safety_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | well tolerated |
CLAIM_RESULT_2fe344b99a3e | CLUST_97b02e6f96d0117c | 30,368,163 | NCT01912196 | efficacy_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_317dac41f572 | CLUST_0f2254e693730824 | 30,358,242 | NCT00892047 | association_claim | associated | source_reported | 6 | PRIMARY; SECONDARY | RESULT_e74b693bc59a; RESULT_cbb9d7c8af75; RESULT_3242fb2e90e0; RESULT_02d7fd1f5293; RESULT_aea42aff5a34; RESULT_083e3339a3e4 | checkable | not_assessed | increased |
CLAIM_RESULT_f6e3c0ac6ebc | CLUST_0f2254e693730824 | 30,358,242 | NCT00892047 | association_claim | associated | source_reported | 6 | PRIMARY; SECONDARY | RESULT_e74b693bc59a; RESULT_cbb9d7c8af75; RESULT_3242fb2e90e0; RESULT_02d7fd1f5293; RESULT_aea42aff5a34; RESULT_083e3339a3e4 | checkable | not_assessed | associated with |
CLAIM_RESULT_5a8054ceac6d | CLUST_0f2254e693730824 | 30,358,242 | NCT01124188 | association_claim | associated | source_reported | 3 | PRIMARY; SECONDARY | RESULT_19359515d22c; RESULT_c197a3ebd6b1; RESULT_56af6ce00788 | checkable | not_assessed | increased |
CLAIM_RESULT_36ec1b1b7628 | CLUST_0f2254e693730824 | 30,358,242 | NCT01124188 | association_claim | associated | source_reported | 3 | PRIMARY; SECONDARY | RESULT_19359515d22c; RESULT_c197a3ebd6b1; RESULT_56af6ce00788 | checkable | not_assessed | associated with |
CLAIM_RESULT_272435f6e01f | CLUST_17006ffef421cc17 | 30,343,455 | NCT00742573 | association_claim | improved | directionally_supported | 2 | PRIMARY | RESULT_cc7442a8b5f8; RESULT_dc8859fb6504 | checkable | not_assessed | associated with |
CLAIM_RESULT_d86e64640219 | CLUST_17006ffef421cc17 | 30,343,455 | NCT00742573 | efficacy_claim | improved | directionally_supported | 2 | PRIMARY | RESULT_cc7442a8b5f8; RESULT_dc8859fb6504 | checkable | not_assessed | efficacy |
CLAIM_RESULT_18c6f55b7961 | CLUST_6318117fa8d081c7 | 30,311,742 | NCT00693849 | no_difference_claim | no_difference | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | did not differ |
CLAIM_RESULT_3e2616021a40 | CLUST_cee8b05826784d28 | 30,270,433 | NCT02562846 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_5e88ce1f425d | CLUST_cee8b05826784d28 | 30,270,433 | NCT02562846 | association_claim | associated | source_reported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_9895f6e4eab4 | CLUST_394b48f3c458466b | 30,256,184 | NCT01298804 | superiority_claim | unclear | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_a669682b3acb | CLUST_c36c28e65a13cf0d | 30,199,128 | NCT00970437 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_7694585e01ab | CLUST_e17857d9acf3d368 | 30,192,444 | NCT02816138 | safety_claim | improved | statistically_supported | 10 | PRIMARY; SECONDARY | RESULT_c63f3bc79fcb; RESULT_af0ce825569e; RESULT_27bc34c14366; RESULT_ba62f380d83c; RESULT_d938aceeb919; RESULT_a8bf96fce83a; RESULT_800c39380d1a; RESULT_02f00cb3706b; RESULT_a5f3b435743c; RESULT_4a3c6dfed800 | checkable | not_assessed | well tolerated |
CLAIM_RESULT_1d5eed337613 | CLUST_4ba344e672a2ec5a | 30,176,835 | NCT02972398 | superiority_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | increased |
CLAIM_RESULT_29b4bd96166f | CLUST_4ba344e672a2ec5a | 30,176,835 | NCT02972398 | efficacy_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_e4b81dc8044d | CLUST_e2aedcafeee72f35 | 30,172,724 | NCT01562184 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_6372b8226467 | CLUST_e2aedcafeee72f35 | 30,172,724 | NCT01562184 | efficacy_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | efficacy |
CLAIM_RESULT_5ee98f7644ce | CLUST_8d7533e39a48acd1 | 30,145,512 | NCT00006286 | superiority_claim | unclear | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | more effective than |
CLAIM_RESULT_dd3056aa9225 | CLUST_471c4f2b6df650c7 | 30,102,427 | NCT02413281 | safety_claim | improved | statistically_supported | 0 | null | null | unverifiable_no_results | not_assessed | safety profile |
CLAIM_RESULT_7ea894d97b89 | CLUST_471c4f2b6df650c7 | 30,102,427 | NCT02413281 | association_claim | improved | directionally_supported | 0 | null | null | unverifiable_no_results | not_assessed | associated with |
CLAIM_RESULT_f279cb462d45 | CLUST_aa0fc10e82fec912 | 30,098,961 | NCT02057406 | superiority_claim | improved | statistically_supported | 2 | PRIMARY | RESULT_347e72cb2fba; RESULT_14f24b2c5e23 | checkable | not_assessed | increased |
CLAIM_RESULT_7f4782b904e4 | CLUST_aa0fc10e82fec912 | 30,098,961 | NCT02057406 | association_claim | improved | directionally_supported | 2 | PRIMARY | RESULT_347e72cb2fba; RESULT_14f24b2c5e23 | checkable | not_assessed | associated with |
CLAIM_RESULT_e70b9c0686ad | CLUST_42cf28b90f23786c | 30,094,160 | NCT00088699 | association_claim | associated | source_reported | 2 | PRIMARY | RESULT_35dc96b4efd4; RESULT_29d3fd110100 | checkable | not_assessed | associated with |
CLAIM_RESULT_ad00a1c1e6a2 | CLUST_bcfdd65aaf56ddae | 30,086,213 | NCT01421134 | superiority_claim | improved | statistically_supported | 7 | PRIMARY; SECONDARY | RESULT_5e16b1a95915; RESULT_d749215dcfc3; RESULT_f2d65cb9b166; RESULT_8a377d969ebd; RESULT_d16b6859d58c; RESULT_3859b72acd62; RESULT_8eb1a0e95312 | checkable | not_assessed | reduced |
CLAIM_RESULT_6e8bd780a0db | CLUST_bcfdd65aaf56ddae | 30,086,213 | NCT01421134 | association_claim | improved | directionally_supported | 7 | PRIMARY; SECONDARY | RESULT_5e16b1a95915; RESULT_d749215dcfc3; RESULT_f2d65cb9b166; RESULT_8a377d969ebd; RESULT_d16b6859d58c; RESULT_3859b72acd62; RESULT_8eb1a0e95312 | checkable | not_assessed | associated with |
CLAIM_RESULT_9f1eda41d491 | CLUST_bcfdd65aaf56ddae | 30,086,213 | NCT01421134 | efficacy_claim | improved | statistically_supported | 7 | PRIMARY; SECONDARY | RESULT_5e16b1a95915; RESULT_d749215dcfc3; RESULT_f2d65cb9b166; RESULT_8a377d969ebd; RESULT_d16b6859d58c; RESULT_3859b72acd62; RESULT_8eb1a0e95312 | checkable | not_assessed | efficacy |
CLAIM_RESULT_1e69e3b6bd3a | CLUST_d97cb4b5f16ee53a | 30,045,066 | NCT00854100 | superiority_claim | no_difference | source_reported | 2 | PRIMARY; SECONDARY | RESULT_36185f897cb9; RESULT_83e7834691c8 | checkable | not_assessed | increased |
CLAIM_RESULT_cc709dfe5d2b | CLUST_d97cb4b5f16ee53a | 30,045,066 | NCT00854100 | no_difference_claim | no_difference | source_reported | 2 | PRIMARY; SECONDARY | RESULT_36185f897cb9; RESULT_83e7834691c8 | checkable | not_assessed | no difference |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.